Replies to post #245646 on Biotech Values

[DewDiligence]

(RVNC)—FDA approves Ajinomoto’s “high potency vial line to manufacture a commercial product”:

https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-receives-fda-approval-for-high-potency-fill-line-301801108.html

The product in question could be Daxxify, based on the timing of the announcement.